| Literature DB >> 12205444 |
Abstract
Pharmacological agents directed against the integrins alpha(v)beta(3) and alpha(v)beta(5) have been reported to inhibit angiogenesis. However, genetic ablations of the genes encoding these integrins fail to block angiogenesis and in some cases even enhance it. This apparent paradox suggests the hypotheses that these integrins are negative regulators of angiogenesis and that the drugs targeting them may be acting as agonists rather than antagonists.Mesh:
Substances:
Year: 2002 PMID: 12205444 DOI: 10.1038/nm0902-918
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440